A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a world-wide pandemic. Internationally, because of availability, accessibility, and distribution issues, there is a need for additional vaccines. This study aimed to: establish the feasibility of personal dendritic cell vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Nistor, Gabriel I., Dillman, Robert O., Robles, Rockelle M., Langford, James L., Poole, Aleksandra J., Sofro, Muchlis A. U., Nency, Yetty M., Jonny, Jonny, Yana, Martina L., Karyana, Mahammad, Lestari, Endang S., Triwardhani, Ria, Mujahidah, Mujahidah, Sari, Retty K., Soetojo, Nur A., Wibisono, Djoko, Tjen, Daniel, Ikrar, Taruna, Sarkissian, Gregory, Winarta, Haryono, Putranto, Terawan A., Keirstead, Hans S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746383/
https://www.ncbi.nlm.nih.gov/pubmed/36018753
http://dx.doi.org/10.1080/21645515.2022.2100189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746383/
https://www.ncbi.nlm.nih.gov/pubmed/36018753
http://dx.doi.org/10.1080/21645515.2022.2100189

Ejemplares similares